HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nathalie Nicot Selected Research
Nathalie Nicot Research Topics
Disease
7
Neoplasms (Cancer)
11/2020 - 07/2011
2
Infections
03/2024 - 03/2015
2
Glioma (Gliomas)
12/2023 - 02/2014
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021 - 10/2020
2
Inflammation (Inflammations)
11/2018 - 04/2014
2
Hepatocellular Carcinoma (Hepatoma)
11/2018 - 03/2017
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
12/2023
1
Genomic Instability
12/2023
1
Neuroinflammatory Diseases
01/2022
1
Parkinson Disease (Parkinson's Disease)
01/2022
1
Hypoxia (Hypoxemia)
01/2019
1
Tics (Tic)
01/2019
1
Cachexia
11/2018
1
Hepatitis B
03/2017
1
Hepatitis
03/2017
1
Liver Cirrhosis (Hepatic Cirrhosis)
03/2017
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2016
1
Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
09/2015
1
Carcinogenesis
04/2014
1
Melanoma (Melanoma, Malignant)
03/2013
Drug/Important Bio-Agent (IBA)
3
Cytokines
IBA
11/2020 - 03/2015
3
Proteins (Proteins, Gene)
FDA Link
11/2018 - 04/2014
2
DNA (Deoxyribonucleic Acid)
IBA
12/2023 - 02/2014
2
Cytarabine (Cytosar-U)
FDA Link
Generic
11/2021 - 10/2020
2
MicroRNAs (MicroRNA)
IBA
01/2019 - 03/2013
2
Interleukin-27 (Interleukin 27)
IBA
11/2018 - 03/2017
2
Ligands
IBA
01/2017 - 12/2016
1
Blood Glucose (Blood Sugar)
IBA
03/2024
1
Corticosterone
IBA
03/2024
1
Chromatin
IBA
12/2023
1
alpha-Synuclein
IBA
01/2022
1
Synucleins
IBA
01/2022
1
venetoclax
IBA
11/2021
1
Adenosine Triphosphate (ATP)
IBA
10/2020
1
Oxygen (Dioxygen)
IBA
01/2019
1
Interleukin-2 (IL2)
IBA
11/2018
1
Antibodies
IBA
11/2018
1
RNA (Ribonucleic Acid)
IBA
01/2017
1
Adenosine A2A Receptor (Adenosine A2A Receptors)
IBA
09/2015
1
Xenobiotics
IBA
04/2014
1
Smoke
IBA
04/2014
1
Janus Kinases
IBA
03/2013
1
Interferons
IBA
03/2013
1
Messenger RNA (mRNA)
IBA
03/2013
1
Cholesterol
IBA
07/2011
Therapy/Procedure
2
Therapeutics
11/2021 - 01/2019